Biopharma company Atrin Pharmaceuticals, a drug discovery and development company focused on molecules targeting DNA damage and repair (DDR) pathways to treat cancer, and gene-based analytics company Predictive Technology Group say they have successfully tested a...
TAMPA, FL / ACCESSWIRE / February 26, 2020 / GT Biopharma, Inc. (OTCQB:GTBP)(GTBP.PA) an immuno-oncology company focused on innovative treatments based on the Company’s proprietary NK cell engager (TriKE™) platform announced today that the first patient has been...
The new law aims to enhance patient participation and retention in cancer clinical trials. Credit: Ernesto Eslava from Pixabay. Illinois lawmakers have introduced new legislation called SB1711, the Clinical Trial Participation Act, that gives all cancer patients...
REDWOOD CITY, Calif., Feb. 26, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company, today announced results from its Phase 2 clinical trial evaluating the safety and efficacy of once daily oral serlopitant for...
— U.S. FDA Grants Investigational New Drug Authorization to Study Remdesivir for the Treatment of COVID-19 — FOSTER CITY, Calif.–(BUSINESS WIRE)–Feb. 26, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced the initiation of two...
Email
Text